Cargando…
Applying Machine Learning to Determine 25(OH)D Threshold Levels Using Data from the AMATERASU Vitamin D Supplementation Trial in Patients with Digestive Tract Cancer
Some controversy remains on thresholds for deficiency or sufficiency of serum 25-hydroxyvitamin D (25(OH)D) levels. Moreover, 25(OH)D levels sufficient for bone health might differ from those required for cancer survival. This study aimed to explore these 25(OH)D threshold levels by applying the mac...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101674/ https://www.ncbi.nlm.nih.gov/pubmed/35565657 http://dx.doi.org/10.3390/nu14091689 |
_version_ | 1784707144454504448 |
---|---|
author | Otani, Katharina Kanno, Kazuki Akutsu, Taisuke Ohdaira, Hironori Suzuki, Yutaka Urashima, Mitsuyoshi |
author_facet | Otani, Katharina Kanno, Kazuki Akutsu, Taisuke Ohdaira, Hironori Suzuki, Yutaka Urashima, Mitsuyoshi |
author_sort | Otani, Katharina |
collection | PubMed |
description | Some controversy remains on thresholds for deficiency or sufficiency of serum 25-hydroxyvitamin D (25(OH)D) levels. Moreover, 25(OH)D levels sufficient for bone health might differ from those required for cancer survival. This study aimed to explore these 25(OH)D threshold levels by applying the machine learning method of multivariable adaptive regression splines (MARS) in post hoc analyses using data from the AMATERASU trial, which randomly assigned Japanese patients with digestive tract cancer to receive vitamin D or placebo supplementation. Using MARS, threshold 25(OH)D levels were estimated as 17 ng/mL for calcium and 29 ng/mL for parathyroid hormone (PTH). Vitamin D supplementation increased calcium levels in patients with baseline 25(OH)D levels ≤17 ng/mL, suggesting deficiency for bone health, but not in those >17 ng/mL. Vitamin D supplementation improved 5-year relapse-free survival (RFS) compared with placebo in patients with intermediate 25(OH)D levels (18–28 ng/mL): vitamin D, 84% vs. placebo, 71%; hazard ratio, 0.49; 95% confidence interval, 0.25–0.96; p = 0.04. In contrast, vitamin D supplementation did not improve 5-year RFS among patients with low (≤17 ng/mL) or with high (≥29 ng/mL) 25(OH)D levels. MARS might be a reliable method with the potential to eliminate guesswork in the estimation of threshold values of biomarkers. |
format | Online Article Text |
id | pubmed-9101674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91016742022-05-14 Applying Machine Learning to Determine 25(OH)D Threshold Levels Using Data from the AMATERASU Vitamin D Supplementation Trial in Patients with Digestive Tract Cancer Otani, Katharina Kanno, Kazuki Akutsu, Taisuke Ohdaira, Hironori Suzuki, Yutaka Urashima, Mitsuyoshi Nutrients Article Some controversy remains on thresholds for deficiency or sufficiency of serum 25-hydroxyvitamin D (25(OH)D) levels. Moreover, 25(OH)D levels sufficient for bone health might differ from those required for cancer survival. This study aimed to explore these 25(OH)D threshold levels by applying the machine learning method of multivariable adaptive regression splines (MARS) in post hoc analyses using data from the AMATERASU trial, which randomly assigned Japanese patients with digestive tract cancer to receive vitamin D or placebo supplementation. Using MARS, threshold 25(OH)D levels were estimated as 17 ng/mL for calcium and 29 ng/mL for parathyroid hormone (PTH). Vitamin D supplementation increased calcium levels in patients with baseline 25(OH)D levels ≤17 ng/mL, suggesting deficiency for bone health, but not in those >17 ng/mL. Vitamin D supplementation improved 5-year relapse-free survival (RFS) compared with placebo in patients with intermediate 25(OH)D levels (18–28 ng/mL): vitamin D, 84% vs. placebo, 71%; hazard ratio, 0.49; 95% confidence interval, 0.25–0.96; p = 0.04. In contrast, vitamin D supplementation did not improve 5-year RFS among patients with low (≤17 ng/mL) or with high (≥29 ng/mL) 25(OH)D levels. MARS might be a reliable method with the potential to eliminate guesswork in the estimation of threshold values of biomarkers. MDPI 2022-04-19 /pmc/articles/PMC9101674/ /pubmed/35565657 http://dx.doi.org/10.3390/nu14091689 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Otani, Katharina Kanno, Kazuki Akutsu, Taisuke Ohdaira, Hironori Suzuki, Yutaka Urashima, Mitsuyoshi Applying Machine Learning to Determine 25(OH)D Threshold Levels Using Data from the AMATERASU Vitamin D Supplementation Trial in Patients with Digestive Tract Cancer |
title | Applying Machine Learning to Determine 25(OH)D Threshold Levels Using Data from the AMATERASU Vitamin D Supplementation Trial in Patients with Digestive Tract Cancer |
title_full | Applying Machine Learning to Determine 25(OH)D Threshold Levels Using Data from the AMATERASU Vitamin D Supplementation Trial in Patients with Digestive Tract Cancer |
title_fullStr | Applying Machine Learning to Determine 25(OH)D Threshold Levels Using Data from the AMATERASU Vitamin D Supplementation Trial in Patients with Digestive Tract Cancer |
title_full_unstemmed | Applying Machine Learning to Determine 25(OH)D Threshold Levels Using Data from the AMATERASU Vitamin D Supplementation Trial in Patients with Digestive Tract Cancer |
title_short | Applying Machine Learning to Determine 25(OH)D Threshold Levels Using Data from the AMATERASU Vitamin D Supplementation Trial in Patients with Digestive Tract Cancer |
title_sort | applying machine learning to determine 25(oh)d threshold levels using data from the amaterasu vitamin d supplementation trial in patients with digestive tract cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101674/ https://www.ncbi.nlm.nih.gov/pubmed/35565657 http://dx.doi.org/10.3390/nu14091689 |
work_keys_str_mv | AT otanikatharina applyingmachinelearningtodetermine25ohdthresholdlevelsusingdatafromtheamaterasuvitamindsupplementationtrialinpatientswithdigestivetractcancer AT kannokazuki applyingmachinelearningtodetermine25ohdthresholdlevelsusingdatafromtheamaterasuvitamindsupplementationtrialinpatientswithdigestivetractcancer AT akutsutaisuke applyingmachinelearningtodetermine25ohdthresholdlevelsusingdatafromtheamaterasuvitamindsupplementationtrialinpatientswithdigestivetractcancer AT ohdairahironori applyingmachinelearningtodetermine25ohdthresholdlevelsusingdatafromtheamaterasuvitamindsupplementationtrialinpatientswithdigestivetractcancer AT suzukiyutaka applyingmachinelearningtodetermine25ohdthresholdlevelsusingdatafromtheamaterasuvitamindsupplementationtrialinpatientswithdigestivetractcancer AT urashimamitsuyoshi applyingmachinelearningtodetermine25ohdthresholdlevelsusingdatafromtheamaterasuvitamindsupplementationtrialinpatientswithdigestivetractcancer |